Chembio Diagnostics Inc. buy stratec
Start price
01.04.20
/
50%
€6.55
Target price
04.11.21
€15.00
Performance (%)
-71.76%
End price
05.11.21
€1.85
Summary
This prediction ended on 05.11.21 with a price of €1.85. Massive losses of -71.76% were the result for the BUY prediction by stratec. stratec has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Chembio Diagnostics Inc. | - | - | - | - |
iShares Core DAX® | 1.804% | -0.748% | 13.168% | 16.408% |
iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% | 43.502% |
iShares Nikkei 225® | 0.413% | -7.381% | 18.776% | 2.874% |
iShares S&P 500 | 0.664% | -1.941% | 28.141% | 42.155% |
Comments by stratec for this prediction
In the thread Chembio Diagn.new diskutieren
Kantor Fitzgerald erneuert sein Buy-Rating mit $7-Preisziel. Chembio Diagnostik stellt Point-of-Care (POC)-Diagnosetests her, die zur Erkennung oder Diagnose von Krankheiten verwendet werden.
Kursziel geändert auf 15,0
In the thread Trading Chembio Diagn.new
Die von stratec gewählte maximale Laufzeit wurde überschritten